# OnCo record tenofovir (drug). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/drugs/tenofovir/>
  a schema:Drug ;
  onco:kind "drug" ;
  schema:identifier "tenofovir" ;
  schema:name "Tenofovir (disoproxil and alafenamide)"@en ;
  schema:alternateName "tenofovir disoproxil fumarate"@en, "TDF"@en, "tenofovir alafenamide"@en, "TAF"@en, "Viread / Vemlidy" ;
  schema:description "Tenofovir is an antiviral tablet for hepatitis B and HIV. Someone with current or past hepatitis B who needs certain cancer treatments takes it to stop the virus flaring up."@en ;
  schema:url <https://onco.cc/drugs/tenofovir/> ;
  schema:dateModified "2026-11-11"^^xsd:date ;
  schema:sameAs <https://en.wikipedia.org/wiki/Tenofovir_disoproxil> ;
  schema:citation <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=33fd6418-fbdc-42ca-a50d-ce2a476a5418>, <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=72e6b33c-0351-4070-9172-eeaa186c01d2>, <https://doi.org/10.1200/JCO.20.01757> ;
  onco:status "approved" ;
  onco:tag "supportive", "generic", "supportive-care-gaps-2026-11" ;
  onco:modality "Antiviral (nucleotide analogue reverse transcriptase inhibitor, oral)" ;
  onco:approval "US 2001: Viread: HIV-1 infection and chronic hepatitis B", "US 2016: Vemlidy: chronic hepatitis B with compensated liver disease" ;
  onco:terms <https://onco.cc/terms/lymphoma-tx-hepatitis-b-reactivation/> .